Private Equity
Andrea Alms Video: Money In Motion 161 - AI Drug Development Market
June 2025 - Private Equity
Andrea Alms Video: Money in Motion 161 - AI Drug Development Market
TRANSCRIPT: Hello, my name is Andrea Alms. I'm a technology investor and financial manager and this is your money in motion. What is it? It is often known that the process of finding and developing new medicines is quite expensive. A new drug development can take anywhere from 9 to 14 years on average, and cost up to $2.6 billion.
Furthermore, very few medicines that are developed reach the market, with an average success rate of 22%. Large volumes of biological and chemical data can be analyzed by artificial intelligence to swiftly find promising drug candidates. Forecast their safety and efficacy, and optimize their design. This means that a new drug candidate drug discovery phase can be shortened to an average of just seven months.
It can benefit drug discovery by one. Accelerating clinical trials targeting identification and value validation. Prediction of drug properties, drug dosage optimization. Pre-clinical testing process genomic data and identify potential side effects. At Emerson Insight, the global market was 3.6 billion in 2022 and forecast to be 1.5 billion by 2025, with an average compound average growth rate of 2620 9.6%.
At clinics, the market was 1.5 billion in 2023, forecast to be 9.1 billion in 2030, growing at 29.7% at market research beers. The market was 109,000,000 in 2022, forecast to be 1.1 billion in 2032, growing at 27.1%. Averaging the averages, the market is 1.74 billion at a 28.8% growth rate. Thank you. This is your money. Your money in motion.